galantamine has been researched along with Down Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, C; Carpenter, PK; Mohan, M | 1 |
| Blatner, M; Busquet, N; de Souza, FM; Maclean, KN; Restrepo, D | 1 |
| Prasher, VP | 1 |
2 review(s) available for galantamine and Down Syndrome
| Article | Year |
|---|---|
Galantamine for dementia in people with Down syndrome.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Down Syndrome; Galantamine; Humans | 2009 |
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Down Syndrome; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine | 2004 |
1 other study(ies) available for galantamine and Down Syndrome
| Article | Year |
|---|---|
Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.
Topics: Animals; Association Learning; Disease Models, Animal; Down Syndrome; Female; Galantamine; Humans; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Nootropic Agents; Odorants; Trisomy | 2011 |